| View |
|
DR-XY33006
|
Paracetamol
|
Phenomed
|
250mg/5mL
|
Syrup
|
-
|
Philmed Laboratories, Inc.
|
Philippines
|
-
|
08 April 2020
|
21 February 2025
|
| View |
|
DR-XY33008
|
Guaifenesin + Dextromethorphan Hydrobromide + Phenylpropanolamine Hydrochloride + Chlorphenamine Maleate
|
Mucobron Forte
|
[see reverse for formulation]
|
Capsule
|
Expectorants/Cough Suppressants/Decongestants/ Antihistamines
|
Medi-Rx ,Inc.
|
Philippines
|
Automatic Renewal
|
23 February 2022
|
21 February 2027
|
| View |
|
DR-XY33009
|
Montelukast (as sodium)
|
Montiget
|
5mg
|
Chewable Tablet
|
Leukotriene Receptor Antagonist
|
Getz Pharma (Private), Limited
|
Pakistan
|
Automatic Renewal
|
30 April 2021
|
05 March 2026
|
| View |
|
DR-XY33010
|
Tobramycin
|
Tobra-V
|
3mg/mL (0.3%
|
Ophthalmic Solution
|
Antibacterial (Aminoglycoside)
|
El Laboratories, Inc
|
Philippines
|
Automatic Renewal
|
13 December 2022
|
26 November 2027
|
| View |
|
DR-XY33015
|
Citicoline
|
Brainact
|
125 mg/mL (250 mg/2mL)
|
Solution for Injection
|
Psychoanaleptic (other psychostimulant and nootropic)
|
P.T. Dankos Farma
|
Indonesia
|
Automatic Renewal
|
30 January 2022
|
22 February 2027
|
| View |
|
DR-XY33041
|
Tamsulosin Hydrochloride
|
Harnal Ocas
|
400mcg
|
Prolonged Release Film-Coated Tablet
|
Alpha-1 Adrenoceptor Antagonist
|
Astellas Pharma Europe B.V.
|
Netherlands
|
Renewal
|
26 April 2022
|
26 February 2027
|
| View |
|
DR-XY33042
|
Metronidazole
|
Medgyl
|
5mg/ mL (500mg/ 100mL)
|
Solution for Injection/Infusion
|
Antibacterial/ Antiprotozoal (Nitroimidazole)
|
Taiwan Biotech Co., Ltd.
|
Taiwan
|
Automatic Renewal
|
22 December 2021
|
26 February 2027
|
| View |
|
DR-XY33081
|
Multivitamins + Iron (Reformulated)
|
Appetite OB
|
FERROUS SULFATE MONOHYDRATE 200MG/FOLIC ACID 400MCG/NICOTINAMIDE 20 MG/THIAMINE MONONITRATE 2 MG/RIBOFLAVIN 2MG/PYRIDOXINE HCL 2MG/CYANOCOBALAMIN 10MCG/ASCORBIC ACID 100MG
|
Capsule
|
Vitamins/ Minerals
|
La Croesus Pharma, Inc.
|
Philippines
|
Renewal
|
20 February 2024
|
07 April 2029
|
| View |
|
DR-XY33087
|
Iron (as Ferrous Fumarate) + Vitamin b12+Folic Acid
|
Ferrovit
|
(see reverse for formulation)
|
Capsule
|
Anti-anemic
|
Mega Lifesciences Public Company Limited
|
Australia
|
Renewal
|
26 October 2023
|
13 March 2029
|
| View |
|
DR-XY33105
|
Methimazole
|
Tapdin
|
20 mg
|
Tablet
|
Antithyroid
|
Sydenham Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
31 January 2022
|
14 March 2027
|
| View |
|
DR-XY33112
|
Ambroxol Hydrochloride
|
Broxitrol
|
15 mg/5 mL
|
Syrup (COLA Flavor)
|
Mucolytic
|
La Croesus Pharma, Inc.
|
Philippines
|
Renewal
|
16 February 2024
|
15 March 2029
|
| View |
|
DR-XY33121
|
Salbutamol (As Sulfate)
|
Emplusal
|
2 mg/5 mL
|
Syrup
|
Selective beta-2-adrenoreceptor agonists
|
J.M. Tolamnn Laboratories Inc.
|
Philippines
|
Automatic Renewal
|
04 February 2022
|
21 March 2027
|
| View |
|
DR-XY33122
|
Salbutamol (As Sulfate)
|
Theoryl
|
2 mg / 5 mL
|
Syrup
|
Bronchodilator
|
J.M. Tolmann Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
28 February 2022
|
21 March 2027
|
| View |
|
DR-XY33129
|
Famotidine
|
H2Bloc
|
20 mg
|
Powder for Injection (I.V./I.M.)
|
H2-receptor antagonists
|
Myung-In Pharm. Co., Ltd.
|
Korea
|
Renewal
|
03 January 2022
|
22 March 2027
|
| View |
|
DR-XY33139
|
Zoledronic Acid
|
Aclasta
|
5 mg/100 mL
|
Solution for Intravenous Infusion
|
Biphosphonate
|
Novartis Pharma Stein AG
|
Switzerland
|
Renewal
|
23 February 2022
|
27 March 2027
|
| View |
|
DR-XY33140
|
Epirubicin Hydrochloride
|
EP Mycin
|
2 mg/mL
|
Solution For Injection
|
Antineoplastic (Cell Cycle-Nonspecific Agent)
|
Boryung Pharmaceutical Co., Ltd.
|
Korea
|
Renewal
|
09 March 2024
|
27 March 2029
|
| View |
|
DR-XY33141
|
Gabapentin
|
Reinin
|
100 mg
|
Capsule
|
Antiepileptics
|
Amherst Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
05 January 2023
|
16 November 2027
|
| View |
|
DR-XY33169
|
PHENYTOIN SODIUM
|
Lantidin
|
50 mg/mL
|
Solution for Injection (I.V.)
|
Antiepileptic (Hydantoin Derivatives)
|
Hanlim Pharmaceutical Co., Ltd.
|
Korea
|
Renewal
|
08 February 2022
|
04 April 2027
|
| View |
|
DR-XY33171
|
Glimepiride
|
Arya
|
1 mg
|
Tablet
|
Blood Glucose Lowering Drugs (sulfonylureas)
|
Lloyd Laboratories,Inc.
|
Philippines
|
Automatic Renewal
|
29 March 2022
|
04 April 2027
|
| View |
|
DR-XY33172
|
Glimepiride
|
Arya
|
3 mg
|
Tablet
|
Blood Glucose Lowering Drugs (Sulfonylureas)
|
Lloyd Laboratories,Inc.
|
Philippines
|
Automatic Renewal
|
29 March 2022
|
04 April 2027
|